New drug duo tested in fight against tough stomach tumors
NCT ID NCT04258956
Summary
This study tested whether combining two drugs, avelumab and axitinib, could help control advanced gastrointestinal stromal tumors (GIST) that had worsened after standard treatments. It involved 58 adults whose cancer had progressed despite prior therapy. The main goal was to see if the combination could keep the cancer from growing for at least three months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL STROMAL TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Maria Sklodowska-Curie National Research Institue of Oncology
Warsaw, 02-781, Poland
Conditions
Explore the condition pages connected to this study.